Robin E. Norris

1.3k total citations
46 papers, 694 citations indexed

About

Robin E. Norris is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Robin E. Norris has authored 46 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 15 papers in Public Health, Environmental and Occupational Health and 12 papers in Hematology. Recurrent topics in Robin E. Norris's work include Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Robin E. Norris is often cited by papers focused on Acute Lymphoblastic Leukemia research (13 papers), Childhood Cancer Survivors' Quality of Life (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Robin E. Norris collaborates with scholars based in United States, Australia and United Kingdom. Robin E. Norris's co-authors include Peter C. Adamson, Elizabeth Fox, Brenda J. Weigel, Vu Thuong Nguyen, Rochelle Bagatell, David T. Teachey, Kim E. Nichols, Daniel M. Green, Patricia Norkool and Michael L. Ritchey and has published in prestigious journals such as Journal of Clinical Oncology, Nature reviews. Cancer and Blood.

In The Last Decade

Robin E. Norris

45 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robin E. Norris United States 14 325 211 149 137 121 46 694
Patrick Thompson United States 15 299 0.9× 192 0.9× 96 0.6× 32 0.2× 47 0.4× 25 644
Kwai Han Yoo South Korea 15 183 0.6× 270 1.3× 210 1.4× 31 0.2× 85 0.7× 50 588
Constantine Alifrangis United Kingdom 10 277 0.9× 130 0.6× 162 1.1× 163 1.2× 38 0.3× 49 741
Kenneth B. DeSantes United States 16 275 0.8× 354 1.7× 82 0.6× 124 0.9× 322 2.7× 32 1.1k
J. L. Pico France 14 231 0.7× 211 1.0× 107 0.7× 174 1.3× 306 2.5× 23 894
Montserrat Domènech Spain 17 317 1.0× 174 0.8× 250 1.7× 71 0.5× 117 1.0× 70 882
Julie Chang United States 14 194 0.6× 383 1.8× 176 1.2× 50 0.4× 72 0.6× 44 806
Roopinder Gillmore United Kingdom 15 176 0.5× 684 3.2× 233 1.6× 73 0.5× 41 0.3× 49 1.3k
Tiffaney L. Vincent United States 11 219 0.7× 221 1.0× 197 1.3× 444 3.2× 441 3.6× 20 954
Marie Jarošová Czechia 17 264 0.8× 136 0.6× 95 0.6× 108 0.8× 354 2.9× 87 766

Countries citing papers authored by Robin E. Norris

Since Specialization
Citations

This map shows the geographic impact of Robin E. Norris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin E. Norris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin E. Norris more than expected).

Fields of papers citing papers by Robin E. Norris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin E. Norris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin E. Norris. The network helps show where Robin E. Norris may publish in the future.

Co-authorship network of co-authors of Robin E. Norris

This figure shows the co-authorship network connecting the top 25 collaborators of Robin E. Norris. A scholar is included among the top collaborators of Robin E. Norris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin E. Norris. Robin E. Norris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
LeBlanc, Francis, Erin H. Breese, Karen Burns, et al.. (2024). Clinical outcomes of hypomethylating agents and venetoclax in newly diagnosed unfit and relapsed/refractory paediatric, adolescent and young adult acute myeloid leukaemia patients. British Journal of Haematology. 205(3). 1055–1066. 3 indexed citations
3.
McGrady, Meghan E., Tyler G. Ketterl, Robin E. Norris, et al.. (2023). Barriers to medication adherence among adolescents and young adults with cancer. Pediatric Blood & Cancer. 70(3). 6 indexed citations
4.
Raetz, Elizabeth A., David T. Teachey, Charles G. Minard, et al.. (2023). Palbociclib in combination with chemotherapy in pediatric and young adult patients with relapsed/refractory acute lymphoblastic leukemia and lymphoma: A Children's Oncology Group study (AINV18P1). Pediatric Blood & Cancer. 70(11). e30609–e30609. 13 indexed citations
5.
Rubinstein, Jeremy D., Erin H. Breese, Maureen M. O’Brien, et al.. (2023). The Choice of Either Conventional Chemotherapy or Inotuzumab Ozogamicin as Bridging Regimen Does Not Appear To Impact Clinical Response to CD19-Directed CAR-T Therapy in Pediatric B-ALL. Transplantation and Cellular Therapy. 29(5). 311.e1–311.e7. 7 indexed citations
6.
Burke, G.A. Amos, Luciana Vinti, Edita Kabíčková, et al.. (2022). Ibrutinib plus RICE or RVICI for relapsed/refractory mature B-cell non-Hodgkin lymphoma in children and young adults: SPARKLE trial. Blood Advances. 7(4). 602–610. 6 indexed citations
7.
McGrady, Meghan E., et al.. (2022). Adherence and Barriers to Inpatient Physical Therapy Among Adolescents and Young Adults with Hematologic Malignancies. Journal of Adolescent and Young Adult Oncology. 11(6). 605–610. 4 indexed citations
8.
McGrady, Meghan E., et al.. (2020). Active and Protected: Developing a “Safer Sex” Handout for Adolescents and Young Adults with Cancer. Journal of Adolescent and Young Adult Oncology. 10(3). 351–354. 2 indexed citations
9.
Yang, Gang, et al.. (2019). Location of Death and End-of-Life Characteristics of Young Adults with Cancer Treated at a Pediatric Hospital. Journal of Adolescent and Young Adult Oncology. 8(4). 417–422. 7 indexed citations
10.
Lacayo, Norman J., Vinod Pullarkat, Wendy Stock, et al.. (2019). Safety and Efficacy of Venetoclax in Combination with Navitoclax in Adult and Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. Blood. 134(Supplement_1). 285–285. 21 indexed citations
11.
Beishuizen, Auke, Deepa Bhojwani, Birgit Burkhardt, et al.. (2019). IBRUTINIB + CHEMOIMMUNOTHERAPY (CIT) FOR RELAPSED/REFRACTORY MATURE B‐CELL NON‐HODGKIN LYMPHOMA (B‐NHL) IN CHILDREN (SPARKLE TRIAL): INITIAL SAFETY, PK, AND EFFICACY. Hematological Oncology. 37(S2). 57–59. 2 indexed citations
12.
McGrady, Meghan E., Robin E. Norris, & Ahna L. H. Pai. (2018). Collaborating with Adolescents and Young Adults with Cancer as Advisors. Journal of Adolescent and Young Adult Oncology. 7(4). 499–503. 3 indexed citations
13.
Norris, Robin E., et al.. (2016). Evaluating the role of phase I expansion cohorts in oncologic drug development. Investigational New Drugs. 35(1). 108–114. 5 indexed citations
14.
Moorthy, Ganesh S., Robin E. Norris, Peter C. Adamson, & Elizabeth Fox. (2014). A liquid chromatography/tandem mass spectrometry method for determination of obatoclax in human plasma. Journal of Chromatography B. 971. 30–34. 1 indexed citations
15.
Norris, Robin E., Vu Thuong Nguyen, & Peter C. Adamson. (2013). Evaluation of the Retinoids With Cisplatin and Vincristine in Xenograft Models of Neuroblastoma. Journal of Pediatric Hematology/Oncology. 36(1). e23–e27. 2 indexed citations
16.
Norris, Robin E. & Peter C. Adamson. (2012). Challenges and opportunities in childhood cancer drug development. Nature reviews. Cancer. 12(11). 776–782. 41 indexed citations
17.
Norris, Robin E., Michele Paessler, & Nancy Bunin. (2009). Donor T-cell–mediated Pancytopenia After Haploidentical Hematopoietic Stem Cell Transplant For Severe Combined Immunodeficiency. Journal of Pediatric Hematology/Oncology. 31(2). 148–150. 6 indexed citations
18.
Beasley, Georgia M., Nicole McMahon, Christina K. Augustine, et al.. (2009). A phase 1 study of systemic ADH‐1 in combination with melphalan via isolated limb infusion in patients with locally advanced in‐transit malignant melanoma. Cancer. 115(20). 4766–4774. 45 indexed citations
19.
Norris, Robin E. & Peter C. Adamson. (2009). Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias. Cancer Chemotherapy and Pharmacology. 65(6). 1125–1130. 17 indexed citations
20.
Chennupati, Sri Kiran, Robin E. Norris, Brian Dunham, & Ken Kazahaya. (2007). Osteosarcoma of the skull base: Case report and review of literature. International Journal of Pediatric Otorhinolaryngology. 72(1). 115–119. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Thompson Breakdown of academic impact, for papers by Kwai Han Yoo Breakdown of academic impact, for papers by Constantine Alifrangis Breakdown of academic impact, for papers by Kenneth B. DeSantes Breakdown of academic impact, for papers by J. L. Pico Breakdown of academic impact, for papers by Montserrat Domènech Breakdown of academic impact, for papers by Julie Chang Breakdown of academic impact, for papers by Roopinder Gillmore Breakdown of academic impact, for papers by Tiffaney L. Vincent Breakdown of academic impact, for papers by Marie Jarošová
Rankless by CCL
2026